Europe Veterinary Vaccines Market 2022-2028

MARKET OUTLOOK

According to the publisher’s report, the veterinary vaccines market in Europe is anticipated to advance at a CAGR of 7.06% from 2022 to 2028. Countries that form the region include the United Kingdom, Germany, Italy, France, Spain, and those in Rest of Europe.

Europe has the presence of dominant international veterinary pharmaceuticals players such as Hester Biosciences Ltd and Virbac SA, influencing the market. Moreover, with advancements in technology, innovation, and R&D, there is an increased demand for vaccines.

The United Kingdom has the largest livestock population within the region, and as a result, the government focuses on providing solutions to animal health-related problems. Additionally, major players deal in pet care products, leading to the increased production of vaccines. Such factors boost the demand for vaccines in the country.

On the other hand, Germany is the third-largest pork producer globally, owing to a high swine population. The country is positioned at the top regarding increasing animal disease. However, with the presence of the world’s largest player, Boehringer Ingelheim, there is a significant growth in the vaccine market in the country.

Similarly, France has a stronghold of market leaders such as Ceva Sante Animale and Virbac SA. Further, investments by leading players in the veterinary public health capabilities have significantly expanded the production capacity for vaccines. Such infrastructural developments lead to the growth of the market.

COMPETITIVE OUTLOOK

The top companies in the veterinary vaccines market include Phibro Animal Health, Vaxxinova GmbH, Elanco Animal Health Inc, Merck Animal Health, Zoetis Inc, and Virbac SA.

1. Europe Veterinary Vaccines Market - Summary

2. Industry Outlook

2.1. Impact of Covid-19 on the Veterinary Vaccines Market
2.2. Key Insights
2.2.1. Increasing Innovation by Market Participants
2.2.2. Advancements in Vaccine and Diagnostic Technology
2.3. Porter's Five Forces Analysis
2.3.1. Threat of New Entrants
2.3.2. Threat of Substitutes
2.3.3. Bargaining Power of Buyers
2.3.4. Bargaining Power of Suppliers
2.3.5. Threat of Competitive Rivalry
2.4. Market Attractiveness Index
2.5. Value Chain Analysis
2.6. Key Buying Criteria
2.7. Regulatory Framework
2.8. Vendor Scorecard
2.9. Key Market Strategies
2.9.1. Mergers & Acquisitions
2.9.2. Contracts & Agreements
2.9.3. Product Launches
2.9.4. Expansions & Divestitures
2.10. Market Drivers
2.10.1. High Vaccine Demand Due to Increasing Animal Population and Diseases
2.10.2. Government-Organized Vaccination Drives
2.10.3. Advanced Vaccine Research and Development
2.11. Market Challenges
2.11.1. Lack of Awareness and Scarcity of Skilled Veterinarians
2.11.2. Stringent Rules and Regulations Pertaining to Vaccine Use
2.12. Market Opportunities
2.12.1. Growing Use of Vaccines in the European Market
2.12.2. Rising Demand for Companion Animals

3. Europe Veterinary Vaccines Market Outlook - by Animal Type

3.1. Livestock Animals
3.1.1. Cattle
3.1.2. Pigs
3.1.3. Poultry
3.1.4. Sheep
3.1.5. Other Livestock Animals
3.2. Companion Animals
3.2.1. Canine
3.2.2. Feline
3.2.3. Equine
3.3. Aquaculture

4. Europe Veterinary Vaccines Market Outlook - by Disease Type

4.1. Canine Disease
4.2. Porcine Disease
4.3. Bovine Disease
4.4. Poultry Disease
4.5. Aquaculture Disease
4.6. Other Disease Types

5. Europe Veterinary Vaccines Market Outlook - by Product Type

5.1. Attenuated Vaccines
5.2. Inactivated Vaccines
5.3. Toxoid Vaccines
5.4. Conjugate Vaccines
5.5. Dna Vaccines
5.6. Recombinant Vaccines
5.7. Subunit Vaccines

6. Europe Veterinary Vaccines Market - Country Outlook

6.1. United Kingdom
6.2. Germany
6.3. France
6.4. Spain
6.5. Italy
6.6. Rest of Europe

7. Competitive Landscape

7.1. Boehringer Ingelheim International GmbH
7.2. Brilliant Bio Pharma
7.3. Ceva Sante Animale
7.4. Elanco Animal Health Inc
7.5. Hester Biosciences Ltd
7.6. Hipra
7.7. Indian Immunologicals Limited
7.8. Merck Animal Health
7.9. Phibro Animal Health
7.10. Vaxxinova GmbH
7.11. Virbac Sa
7.12. Zoetis Inc

8. Research Methodology & Scope

8.1. Research Scope & Deliverables
8.2. Sources of Data
8.3. Research Methodology

List of Tables

Table 1: Europe Veterinary Vaccines Market, by Country, 2022-2028 (In $ Million)
Table 2: Regulatory Framework
Table 3: Vendor Scorecard
Table 4: Europe Veterinary Vaccines Market, by Animal Type, 2022-2028 (In $ Million)
Table 5: Europe Veterinary Vaccines Market, by Livestock Animals, 2022-2028 (In $ Million)
Table 6: Europe Veterinary Vaccines Market, by Companion Animals, 2022-2028 (In $ Million)
Table 7: Europe Veterinary Vaccines Market, by Disease Type, 2022-2028 (In $ Million)
Table 8: Europe Veterinary Vaccines Market, by Product Type, 2022-2028 (In $ Million)
Table 9: Europe Veterinary Vaccines Market, by Country Outlook, 2022-2028 (In $ Million)

List of Figures

Figure 1: Market Attractiveness Index
Figure 2: Value Chain Analysis
Figure 3: Key Buying Criteria
Figure 4: Europe Veterinary Vaccines Market, by Animal Type, 2021 & 2028 (In %)
Figure 5: Europe Veterinary Vaccines Market, by Livestock Animals, 2022-2028 (In $ Million)
Figure 6: Europe Veterinary Vaccines Market, by Livestock Animals, 2021 & 2028 (In %)
Figure 7: Europe Veterinary Vaccines Market, by Cattle, 2022-2028 (In $ Million)
Figure 8: Europe Veterinary Vaccines Market, by Pigs, 2022-2028 (In $ Million)
Figure 9: Europe Veterinary Vaccines Market, by Poultry, 2022-2028 (In $ Million)
Figure 10: Europe Veterinary Vaccines Market, by Sheep, 2022-2028 (In $ Million)
Figure 11: Europe Veterinary Vaccines Market, by Other Livestock Animals, 2022-2028 (In $ Million)
Figure 12: Europe Veterinary Vaccines Market, by Companion Animals, 2022-2028 (In $ Million)
Figure 13: Europe Veterinary Vaccines Market, by Companion Animals, 2021 & 2028 (In %)
Figure 14: Europe Veterinary Vaccines Market, by Canine, 2022-2028 (In $ Million)
Figure 15: Europe Veterinary Vaccines Market, by Feline, 2022-2028 (In $ Million)
Figure 16: Europe Veterinary Vaccines Market, by Equine, 2022-2028 (In $ Million)
Figure 17: Europe Veterinary Vaccines Market, by Aquaculture, 2022-2028 (In $ Million)
Figure 18: Europe Veterinary Vaccines Market, by Disease Type, 2021 & 2028 (In %)
Figure 19: Europe Veterinary Vaccines Market, by Canine Disease, 2022-2028 (In $ Million)
Figure 20: Europe Veterinary Vaccines Market, by Porcine Disease, 2022-2028 (In $ Million)
Figure 21: Europe Veterinary Vaccines Market, by Bovine Disease, 2022-2028 (In $ Million)
Figure 22: Europe Veterinary Vaccines Market, by Poultry Disease, 2022-2028 (In $ Million)
Figure 23: Europe Veterinary Vaccines Market, by Aquaculture Disease, 2022-2028 (In $ Million)
Figure 24: Europe Veterinary Vaccines Market, by Other Disease Type, 2022-2028 (In $ Million)
Figure 25: Europe Veterinary Vaccines Market, by Product Type, 2021 & 2028 (In %)
Figure 26: Europe Veterinary Vaccines Market, by Attenuated Vaccines, 2022-2028 (In $ Million)
Figure 27: Europe Veterinary Vaccines Market, by Inactivated Vaccines, 2022-2028 (In $ Million)
Figure 28: Europe Veterinary Vaccines Market, by Toxoid Vaccines, 2022-2028 (In $ Million)
Figure 29: Europe Veterinary Vaccines Market, by Conjugate Vaccines, 2022-2028 (In $ Million)
Figure 30: Europe Veterinary Vaccines Market, by Dna Vaccines, 2022-2028 (In $ Million)
Figure 31: Europe Veterinary Vaccines Market, by Recombinant Vaccines, 2022-2028 (In $ Million)
Figure 32: Europe Veterinary Vaccines Market, by Subunit Vaccines, 2022-2028 (In $ Million)
Figure 33: Europe Veterinary Vaccines Market, Country Outlook, 2021 & 2028 (In %)
Figure 34: United Kingdom Veterinary Vaccines Market 2022-2028 (In $ Million)
Figure 35: Germany Veterinary Vaccines Market 2022-2028 (In $ Million)
Figure 36: France Veterinary Vaccines Market 2022-2028 (In $ Million)
Figure 37: Spain Veterinary Vaccines Market 2022-2028 (In $ Million)
Figure 38: Italy Veterinary Vaccines Market 2022-2028 (In $ Million)
Figure 39: Rest of Europe Veterinary Vaccines Market 2022-2028 (In $ Million)